首页 › 癌症（所有类型） › 加利福尼亚州 › San Francisco
San Francisco CA 癌症（所有类型）临床试验
35项针对 癌症（所有类型）的研究正在 San Francisco及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
PediRISE Feasibility
招募中
- University of California San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
招募中
- Kaiser Permanente-San Francisco, San Francisco
Intratumoral N17350 in Advanced Solid Tumors
招募中1/2 期
- University of California, San Francisco, San Francisco
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- Kaiser Permanente - South San Francisco Medical Center, San Francisco
- California Pacific Medical Center Research Institute, San Francisco
- Kaiser Permanente - San Francisco Medical Center, San Francisco
- 以及另外 1 项
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- University of California, San Francisco- California, San Francisco
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
招募中观察性研究
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
招募中观察性研究
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- UCSF, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
招募中1 期
- UCSF, San Francisco
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
International Rare Brain Tumor Registry
招募中观察性研究
- University of California San Francisco, San Francisco
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
招募中
- Stanford Cancer Institute, San Francisco
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
招募中2 期
- The Unviersity of California, San Francisco (UCSF), San Francisco
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
招募中2 期
- 014, San Francisco
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
招募中1/2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
招募中1 期
- University of California San Francisco, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- UCSF Medical Center at Mission Bay, San Francisco
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- UCSF Medical Center - Mission Bay, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Childhood Cancer Survivor Study
招募中观察性研究欢迎健康志愿者
- University of California-San Francisco, San Francisco
Multisite Implementation of COMPRENDO
招募中欢迎健康志愿者
- University of California San Francisco Benioff Children's Hospitals, San Francisco
Galleri® in the Medicare Population.
招募中欢迎健康志愿者
- University of California San Francisco Health System, San Francisco
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
招募中2 期
- University of California San Francisco (UCSF), San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
招募中1 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
招募中
- University of California, San Francisco, San Francisco
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
招募中1/2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Primary Tumor Research and Outcomes Network
招募中观察性研究
- UCSF Medical Center, San Francisco
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
招募中观察性研究
- University of California San Francisco, San Francisco
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
招募中2 期
- University of California, San Francisco, San Francisco
ChangeGradients: Promoting Adolescent Health Behavior Change
招募中欢迎健康志愿者
- University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, San Francisco
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- University of California, San Francisco, San Francisco
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY109 项研究
- Boston, MA85 项研究
- Los Angeles, CA74 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Washington, DC58 项研究
- Durham, NC58 项研究
- Chicago, IL51 项研究
- Atlanta, GA49 项研究
- Seattle, WA49 项研究
- Arlington, VA48 项研究
San Francisco的其他研究
- 前列腺癌45 项研究
- 乳腺癌43 项研究
- 非小细胞肺癌36 项研究
- 心力衰竭29 项研究
- 转移性癌症28 项研究
- 肺癌22 项研究
- 黑色素瘤22 项研究
- 胰腺癌20 项研究
- 卵巢癌19 项研究
- 结直肠癌18 项研究
- 心血管疾病18 项研究
- 胶质母细胞瘤17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。